On July 29, 2025, Windtree Therapeutics, Inc. accepted the resignation of Leanne Kelly from its Board of Directors and appointed Andrew Kucharchuk as her replacement effective immediately. Kucharchuk has a strong background, having served in various financial leadership roles, including as CFO at Cero Therapeutics Holdings, Inc.